GJC1 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Notably, studies in a dysferlinopathy mouse model demonstrated muscle and systemic protection when myofibers were deficient in Cx43 and Cx45 expression, suggesting that muscle atrophy mechanisms are downstream of these Cxs [107].